| Literature DB >> 29854616 |
R M Kartheek1, M David1.
Abstract
Extensive pesticide application has contributed to environmental contamination globally, imposing adverse health effects on non-target organisms. Need for an understanding of cellular response following pesticide exposure is, therefore, paradigmatic for elucidating perturbations occurring within biological systems. The present investigation was aimed to examine safe and toxic dose level of a persistent, synthetic, phenylpyrazole based insecticide, Fipronil (FPN) on rat liver. Experimental animals were divided into four groups and gavaged with 0.0 (control), 32.33 (high), 12.12 (medium) and 6.46 mg/kg body weight/day (low dose) of FPN for 90 days. While results for liver catalase and glutathione S-transferase indicated significant changes in high and medium dose groups, the superoxide dismutase and glutathione peroxidase activity suggested significant changes in all exposed groups as compared to control. Elevated levels of liver malondialdehyde reflected oxidative damage potential under the exposed groups but remained insignificant for low dose. Histologically, structural irregularities with findings like impaired portal vein and hypertrophy of hepatocytes were prominent under all the exposed groups. The FT-IR based spectral investigation further revealed changes in absorption patterns and peak intensities in rats exposed to FPN. Significant elevation was also noticed in liver enzymes; alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase in rat serum suggesting the toxicity in dose -dependent pattern. Based on the outcome, it could be ascertained that the toxicity of FPN is certain at high and medium dose levels but remains ambiguous at a low dose of 6.46 mg/kg body weight/day. The current upshots serve as a preliminary report thereby advising the farming community against the usage of FPN insecticide.Entities:
Keywords: Antioxidants; Fipronil; Hepatotoxicity; Necrosis; Pesticide
Year: 2018 PMID: 29854616 PMCID: PMC5978010 DOI: 10.1016/j.toxrep.2018.02.019
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Fig. 1Changes in body weight gain of male rats under control and exposed group.
Changes in antioxidant status of wistar rats on exposure to selected doses of fipronil.
| Sl. No. | Parameter | Groups | |||
|---|---|---|---|---|---|
| Control | Exposed | ||||
| High | Medium | Low | |||
| 1. | Catalase (U/mg protein) | 13.26 ± 0.19 | 6.05 ± 0.43 | 10.45 ± 0.87 | 14.09 ± 0.52 |
| 2. | Superoxide dismutase (U/mg protein) | 48.37 ± 0.27 | 22.01 ± 0.8 | 24.94 ± 0.66 | 60.41 ± 0.72 |
| 3. | Glutathione peroxidase (U/mg protein) | 190.07 ± 1.14 | 51.77 ± 0.93 | 124.94 ± 0.44* | 156.41 ± 0.91 |
| 4. | Glutathione S-transferase (U/mg protein) | 45.11 ± 0.71 | 19.77 ± 0.29 | 24.51 ± 0.53 | 42.64 ± 0.66 |
| 5. | Malondialdehyde (nmol of MDA formed/mg protein) | 2.01 ± 0.08 | 7.33 ± 0.44 | 4.15 ± 0.13 | 2.59 ± 0.22 |
Values represented in groups are means ± SE; significantly different from control.
p < 0.05.
p < 0.01.
Histopathological changes in liver of male Wistar rats following oral exposure to different doses of FPN.
| Findings | Groups | |||
|---|---|---|---|---|
| Control | Exposed | |||
| High | Medium | Low | ||
| Vacuolation (V) | ND | * * | * * | * |
| Dilated sinusoid (DS) | ND | * * | * * | ND |
| Hypertrophy of hepatocytes (H) | ND | * * * | * * | * |
| Stagnation of bile (B) | ND | * | ** | ND |
| Damaged hepatic artery (HA) | ND | * | * * | ND |
| Degeneration/Clogging of bile duct (BD) | ND | * * * * | * * * | ND |
| Focal necrosis (F) | ND | * | ND | ND |
| Degenerated/Thrombosis/Clogged portal vein (PV) | ND | ND | ND | * * * * |
Histopathological findings in the liver of male Wistar albino rats with different groups indicated, (ND) as Not detected, (*) as low, (* *) as medium, (* * *) as high and (* * * *) as severe levels of histoarchitectural damage.
Fig. 2Photomicrograph showing sections of rat liver of Control (0.0 mg/kg BW/day) a: Hepatocytes (H), Portal Vein (PV), Blood sinusoids (BS), Hepatic Artery (HA), Bile Duct (BD), interlobular Connective Tissue; rats exposed to High dose (32.33 mg/kg BW/day) b: Damaged Bile Duct (BD), Ruptured Portal Vein (PV), dilated blood sinusoids (BS), Damaged Hepatic Artery (HA), Hypertrophy of Hepatocytes (H), Disrupted Connective Tissue (CT), Focal Necrosis (F); rats exposed to medium dose (12.12 mg/kg BW/day) c: Mild Dilation of Blood Sinusoids (BS), Partial clogging of Bile Duct (BD) and Portal Vein (PV), Damaged Hepatic Artery (HA) and Connective Tissue (CT), Hypertrophy of Hepatocytes (H), Stagnation of Bile (B), mild Vacuolation (V), Focal Necrosis (F); rats exposed to with low dose (6.46 mg/kg BW/day) d: Hypertrophy of Hepatocytes (H), Clogged Portal Vein (PV), (H and E staining, 200 X).
Fig. 3Photomicrograph showing control and FPN exposed sections of rat liver; notice intact hepatocytes, blood sinusoids, portal vein, and bile duct in (a): Control (0.0 mg/kg BW/day); Degenerated hepatocytes, damaged portal vein, bile duct and necrotized area around portal vein (b): High dose- 32.33 mg/kg BW/day, c: Medium dose- 12.12 mg/kg BW/day and (d): Low dose- 6.46 mg/kg BW/day (H and E staining, processed with ImageJ, 200 X).
General band assignments for FTIR spectra of the liver of rats under control and groups exposed to sublethal doses of FPN.
| Peak | Groups | Assignments of peaks | |||
|---|---|---|---|---|---|
| Control | Exposed | ||||
| High | Medium | Low | |||
| 1 | 3406 | 3428 | 3413 | 3303 | Amine N—H asymmetric stretching |
| 2 | 2925 | 2924 | 2924 | 2924 | CH3 asymmetric stretching: mainly lipids |
| 3 | 2854 | 2855 | 2857 | 2854 | CH2 asymmetric stretching: mainly lipids |
| 4 | 1652 | 1642 | 1652 | 1654 | Amide I: Protein C |
| 5 | 1546 | 1550 | 1543 | 1545 | Amide II: Protein N—H bending, C—N stretching |
| 6 | 1454 | 1456 | 1452 | 1454 | C—H bending (scissoring) (in CH3groups)/aromatic —C |
| 7 | 1402 | 1383 | 1400 | 1399 | –OH bending vibrations, —C—O—H in-plane bending vibrations,—CH3 out-of-plane bending vibrations, —CH2— wagging and twisting vibrations |
| 8 | 1238 | 1268 | 1315 | 1315 | C(O)—O stretching vibrations and —OH in plane vibrations/amide III (e.g. in aromatic ethers) |
| 9 | 1149 | 1162 | 1241 | 1239 | C—O stretching vibrations (e.g. in C—O—C glycosidic linkages of oligosaccharides or in triacylglycerols) |
| 10 | 1079 | 1036 | 1080 | 1081 | PO2− symmetric stretching: Phospholipids and nucleic acids |
| 11 | 925 | 806 | 870 | 926 | γzOH of carboxylic group |
Fig. 4Co-added and overlaid infrared spectra (4000–500 cm−1 spectral region) of liver tissue for the control (0.0) and groups treated with high (32.33), medium (12.12) and low (6.46 mg/kg BW) dose of FPN.
Changes in the absorption of IR peaks in the liver of male Wistar rats following oral administration to different doses of FPN.
| Range | Groups | ||||
|---|---|---|---|---|---|
| Peak | Control | Exposed | |||
| High | Medium | Low | |||
| 1 | 3303–3428 | 144.39 | 29.83 | 36.139 | 76.708 |
| 2 | 2924–2925 | 2.189 | 0.602 | 0.722 | 1.584 |
| 3 | 2854–2857 | 0.678 | 0.159 | 0.366 | 0.647 |
| 4 | 1642–1654 | 18.283 | 2.927 | 6.038 | 15.124 |
| 5 | 1543–1550 | 6.45 | 0.241 | 2.34 | 7.157 |
| 6 | 1452–1456 | 1.031 | 0.145 | 0.452 | 1.017 |
| 7 | 1383–1402 | 0.929 | 0.019 | 0.373 | 0.947 |
| 8 | 1268–1328 | 1.154 | 0.03 | 0.381 | 1.166 |
| 9 | 1156–1241 | 0.181 | 0.05 | 0.055 | 0.143 |
| 10 | 1036–1081 | 0.534 | 0.041 | 0.065 | 0.483 |
| 11 | 806–926 | 0.605 | 0.137 | 0.046 | 0.401 |
Changes in serum biochemical levels of wistar rats on exposure to selected doses of FPN.
| Sl. No. | Parameter | Groups | |||
|---|---|---|---|---|---|
| Control | Exposed | ||||
| High | Medium | Low | |||
| 6. | Aspartate aminotransferase | 85.01 ± 2.64 | 242.19 ± 2.22 | 115.16 ± 1.47 | 109.44 ± 1.44 |
| 7. | Alanine aminotransferase | 55.37 ± 1.97 | 223.71 ± 2.64 | 101.03 ± 2.46 | 81.06 ± 0.91 |
| 8. | Alkaline phosphatase | 133.88 ± 2.42 | 354.91 ± 3.46 | 300.46 ± 3.32 | 148.13 ± 2.31 |
Values represented in groups are means ± SE; significantly different from control.
p < 0.05.
p < 0.01.